Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards

Diseasesort descending Cell Type Therapeutic or Technology Institution Stage Project Objective Details
Immune Disease,
Severe Combined Immunodeficiency, X-linked (X-SCID)
Adult Stem Cell Gene-modified, personalized cell therapy St. Jude
Clinical Trial, Phase 1 or Phase 1/2
Intervertebral disc degeneration iPS Cell Donor cell therapy Cedars-Sinai
Proof of Concept
Intestinal Disease iPS Cell Exploring disease mechanisms Cedars-Sinai
Proof of Concept, Tool/Resources/Bottleneck
Intestinal Disease,
Neurological Disorders
iPS Cell Donor cell therapy CHLA
Pre-IND/IDE or Equivalent
IPEX Syndrome Adult Stem Cell Gene-modified, personalized cell therapy Stanford
Clinical Trial, Phase 1 or Phase 1/2
IPEX Syndrome Adult Stem Cell Gene-modified, personalized cell therapy ImmunoVec
Pre-IND/IDE or Equivalent
Kidney Disease Somatic Cell Gene Therapy, cell free UCSF
Development Candidate, Proof of Concept
Kidney Failure Adult Stem Cell Donor cell therapy Stanford
Clinical Trial, Phase 1 or Phase 1/2
Kidney Failure Adult Stem Cell Donor cell therapy Medeor Therapeutics
Clinical Trial, Phase 3
Kidney Failure Adult Stem Cell Device UC Davis
Pre-IND/IDE or Equivalent
Kidney Failure Adult Stem Cell Donor cell therapy Stanford
Clinical Trial, Phase 1 or Phase 1/2
Leukemia Cancer Stem Cell Biologic UCLA
Development Candidate
Leukemia, Acute Myeloid (AML) Cancer Stem Cell Gene-modified, personalized cell therapy UCSF
IND
Leukemia, Acute Myeloid (AML) Cancer Stem Cell Gene-modified, personalized cell therapy UCSF
Pre-IND/IDE or Equivalent
Leukemia, Acute Myeloid (AML) Cancer Stem Cell Antibody Immune-Onc Therapeutics
Clinical Trial, Phase 1 or Phase 1/2
Liver Disease iPS Cell Diagnostic Test UCSF
Development Candidate, Proof of Concept
Liver Disease iPS Cell Gene-modified, donor cell therapy CHLA
Development Candidate, Proof of Concept
Lung Cancer Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Clinical Trial, Phase 1 or Phase 1/2
Lung Disease, Fibrosis Adult Stem Cell Small molecule therapy Rubedo Life Sciences Inc.
Development Candidate, Proof of Concept
Melanoma Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Pre-IND/IDE or Equivalent
Melanoma Adult Stem Cell Vaccine UCLA
Proof of Concept
Metabolic Disorders,
Neurological Disorders
Somatic Cell Stanford
IND
Metabolic Disorders Adult Stem Cell Gene-modified, personalized cell therapy Rampart Bioscience
IND
Metabolic Disorders Somatic Cell Gene-modified, personalized cell therapy Immusoft Corporation
Pre-IND/IDE or Equivalent
Multiple Myeloma Adult Stem Cell Gene-modified, donor cell therapy UCLA
Pre-IND/IDE or Equivalent
Multiple Myeloma Adult Stem Cell Personalized cell therapy UCLA
Pre-IND/IDE or Equivalent
Multiple Myeloma Somatic Cell Gene-modified, personalized cell therapy UCSF
Development Candidate, Proof of Concept
Multiple Myeloma Adult Stem Cell Gene-modified, personalized cell therapy Poseida Therapeutics
Clinical Trial, Phase 1 or Phase 1/2
Multiple Sclerosis Adult Stem Cell Small molecule therapy Scripps
Development Candidate, Proof of Concept
Skeletal/Smooth Muscle disorders Embryonic Stem Cell,
iPS Cell
Exosomes based therapy Stanford
Development Candidate, Proof of Concept
Muscle Injury Adult Stem Cell Personalized cell therapy UC Davis
Clinical Trial, Phase 1 or Phase 1/2
Muscle Injury Adult Stem Cell Other Components UCSF
Development Candidate, Proof of Concept
Muscular Dystrophy Protein/peptide therapy Juvena Therapeutics Inc
Pre-IND/IDE or Equivalent
Neurological Disorders iPS Cell Gene Therapy, cell free Navega Therapeutics
Development Candidate, Proof of Concept
Neurological Disorders,
Sanfilippo Syndrome/MPS III
Embryonic Stem Cell Gene-modified, donor cell therapy Lundquist Institute
Development Candidate, Proof of Concept
Neurological Disorders,
Sanfilippo Syndrome/MPS III
iPS Cell Gene-modified, personalized cell therapy UC Irvine
Development Candidate, Proof of Concept
Neurological Disorders,
Other
Adult Stem Cell Gene-modified, personalized cell therapy UCSD
Pre-IND/IDE or Equivalent
Neurological Disorders Gene Therapy, cell free Mahzi Therapeutics
Pre-IND/IDE or Equivalent
Neurological Disorders Adult Stem Cell Gene-modified, personalized cell therapy UC Davis
IND
Osteoarthritis Somatic Cell Gene Therapy, cell free Genascence Corporation
Clinical Trial, Phase 1 or Phase 1/2
Other Adult Stem Cell Protein/peptide therapy Intact Therapeutics, Inc.
Development Candidate, Proof of Concept
Other iPS Cell Model system development Greenstone Biosciences
Tool/Resources/Bottleneck
Ovarian Cancer Adult Stem Cell Gene-modified, donor cell therapy COH
Pre-IND/IDE or Equivalent
Ovarian Cancer Adult Stem Cell Gene-modified, donor cell therapy UCLA
Development Candidate
Ovarian Cancer iPS Cell Gene-modified, donor cell therapy UCSD
Development Candidate, Proof of Concept
Pancreatic Cancer Cancer Stem Cell Antibody UCSD
Development Candidate
Pancreatic Cancer Cancer Stem Cell Small molecule therapy UCSD
Development Candidate, Proof of Concept
Parkinson's Disease iPS Cell Donor cell therapy Ryne Bio
IND
Parkinson's Disease Vital Research Opportunity Gene Therapy, cell free Brain Neurotherapy Bio
Clinical Trial, Phase 1 or Phase 1/2
Prostate Cancer iPS Cell Gene-modified, donor cell therapy COH
Development Candidate, Proof of Concept

Pages

Icon for csv export